Nástroje

iconicon Akciový screener
iconicon Kalendář zisků
iconicon Super investoři

Ostatní

iconicon Návod
IČ: 19940963

5. května 521, 501 01 Turnov
Zásady GDPR
Podmínky služby
Všechna práva vyhrazena @ 2024, Fundamenty.cz
Proudly created by draftspot.net
Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc.
HRMY
Valuace
83
Růst
100
Zdraví
49
Cena
$ 31.58
Dnes
--0.19 (-0.52%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
1.8B
Obrat
1B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
0%
ROA
0%
PE
10
PS
2
Cena 1R
26-41
⌀ Cena
33.39
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
24-02-2026
Poslední dividenda

Profil

Harmony Biosciences Holdings, Inc., komerční farmaceutická společnost, vyvíjí a komercializuje terapie pro pacienty se vzácnými neurologickými poruchami ve Spojených státech. Jeho produktem je přípravek WAKIX určený k léčbě nadměrné denní ospalosti u dospělých pacientů s narkolepsií. Společnost byla dříve známá jako Harmony Biosciences II, Inc. a v únoru 2020 změnila svůj název na Harmony Biosciences Holdings, Inc. Společnost Harmony Biosciences Holdings, Inc. byla založena v roce 2017 a sídlí v Plymouth Meeting v Pensylvánii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
268
Založení
2020-08-19
Adresa
630 West Germantown Pike
CEO
Jeffrey M. Dayno
Web
www.harmonybiosciences.com

Podobné společnosti

VERA
Vera Therapeutics, Inc.
$ 28.27
+ $ 4.08
AUPH
Aurinia Pharmaceuticals Inc.
$ 14.80
+ $ 0.19
CLDX
Celldex Therapeutics, Inc.
$ 22.78
- $ 0.12
MNKD
MannKind Corporation
$ 5.32
- $ 0.31
JANX
Janux Therapeutics, Inc.
$ 27.09
+ $ 0.61
BHVN
Biohaven Ltd.
$ 8.11
- $ 0.16
ABCL
AbCellera Biologics Inc.
$ 3.89
- $ 0.03

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 20252024202320222021202020192018
Total Revenues868.5868.5714.7582.0437.9305.4159.76.00.0
Cost of Revenues198.3198.3156.8121.283.555.527.71.60.0
Gross Profit670.1670.1557.9460.8354.4249.9132.04.40.0
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues243.8239.5200.5184.7201.3186.0172.8154.6168.4160.3
Cost of Revenues68.559.738.232.054.442.832.127.543.232.3
Gross Profit175.2179.8162.3152.7146.9143.3140.7127.1125.3128.0
Operating Income TTM 20252024202320222021202020192018
R&D Expenses0.00.00.076.170.930.419.469.612.4
Selling General & Admin Expenses0.00.00.0192.7163.3132.095.680.729.1
Depreciation & Amortization25.325.324.124.40.218.810.23.20.2
Total Operating Expenses461.6461.6367.1268.8234.2162.4115.0150.341.4
Operating Income208.5208.5190.8192.0120.268.73.7-145.9-41.4
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.030.317.5
Selling General & Admin Expenses0.00.00.00.00.00.00.00.054.846.0
Depreciation & Amortization7.46.06.06.06.06.06.16.16.16.1
Total Operating Expenses136.7114.3114.296.591.181.6119.375.185.163.5
Operating Income38.665.548.256.255.761.721.452.040.264.5
Net Income TTM 20252024202320222021202020192018
Interest Income21.921.918.514.70.00.00.00.00.0
Interest Expense14.614.617.523.815.724.028.20.00.0
Other Expense6.66.61.0-18.6-15.5-31.3-40.6-6.11.5
IBT215.1215.1191.8173.4104.737.4-36.9-152.0-39.9
Income Tax Expense56.456.446.344.5-76.82.814.96.11.5
Net Income158.7158.7145.5128.9181.534.6-51.9-158.1-39.9
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income5.95.75.35.04.54.94.74.44.14.1
Interest Expense3.53.63.63.84.24.34.44.515.42.9
Other Expense2.22.01.50.90.40.50.3-0.2-0.5-12.7
IBT40.867.549.657.256.262.221.751.839.751.8
Income Tax Expense18.316.69.911.66.716.110.113.513.113.4
Net Income22.550.939.845.649.546.111.638.326.638.5
Per Share Data TTM 20252024202320222021202020192018
EPS$0.00$0.00$0.00$2.17$3.14$0.60$-2.01$-2.86$-0.81
EPS Diluted$0.00$0.00$0.00$2.13$3.14$0.58$-2.01$-2.86$-0.81
Shares Outstanding57.657.556.959.559.257.525.855.349.2
Diluted Shares Outstanding58.758.557.960.461.159.225.855.349.2
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.46$0.64
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.45$0.63
Shares Outstanding57.658.557.557.357.156.956.856.858.359.9
Diluted Shares Outstanding58.758.758.458.558.258.157.557.658.960.7
Current Assets TTM 2024202320222021202020192018
Cash And Equivalents317.3453.0311.7243.8234.3228.624.583.5
Short Term Investments29.614.241.879.30.00.00.00.0
Total Cash & ST Investments346.9467.2353.5323.1234.3228.624.583.5
Accounts Receivable83.283.074.154.734.822.24.30.0
Inventory5.67.25.44.34.43.81.10.0
Other Current Assets22.621.818.18.83.21.30.32.5
Total Current Assets458.3579.3451.1400.3284.4262.931.586.7
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents647.0546.1489.0453.0387.4317.3333.0311.7324.6317.4
Short Term Investments25.619.218.014.223.129.639.441.846.153.6
Total Cash & ST Investments672.6565.3507.0467.2410.5346.9372.4353.5370.7371.0
Accounts Receivable100.793.0106.083.081.583.279.774.167.363.8
Inventory6.96.16.47.26.95.65.95.45.14.9
Other Current Assets58.727.023.421.823.522.621.618.120.016.0
Total Current Assets838.8691.4642.7579.3522.4458.3479.5451.1463.0455.6
Long-Term Assets TTM 2024202320222021202020192018
Net Property, Plant & Equipment3.33.40.40.60.80.91.31.6
Goodwill0.00.00.00.00.00.00.00.0
Intangible Assets125.2113.3137.1161.0143.9162.372.20.0
Long-Term Investments87.4108.972.222.60.00.00.00.0
Other Long-Term Assets4.0194.46.63.54.30.91.71.0
Total Long-Term Assets400.0419.9360.4273.6149.0164.275.22.6
Total Assets858.4999.2811.4673.9433.4427.1106.789.3
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment2.72.73.13.43.13.33.30.40.40.6
Goodwill0.00.00.00.00.00.00.00.00.00.0
Intangible Assets95.4101.3107.3113.3119.2125.2131.1137.1143.1149.0
Long-Term Investments105.8107.0103.2108.994.287.281.272.267.758.7
Other Long-Term Assets165.5205.7199.2194.4189.2184.4151.86.63.12.7
Total Long-Term Assets369.4416.7412.8419.9405.7400.0367.5360.4314.8304.5
Total Assets1,208.21,108.01,055.5999.2928.1858.4847.0811.4777.8760.2
Current Liabilities TTM 2024202320222021202020192018
Accounts Payable22.713.717.73.81.02.66.41.5
Short-Term Debt47.017.615.02.02.00.00.00.0
Other Current Liabilities76.9143.8131.173.11.4132.013.55.8
Current Liabilities146.6175.1163.878.953.8134.519.97.2
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable26.328.317.513.710.522.715.117.76.56.6
Short-Term Debt20.819.618.617.616.516.816.815.015.011.0
Other Current Liabilities176.2132.2139.0143.8134.2107.1122.3131.190.975.5
Current Liabilities223.4180.1175.1175.1161.3146.6154.3163.8112.493.0
Long-Term Liabilities TTM 2024202320222021202020192018
Long-Term Debt171.4163.8178.6189.6190.0194.397.90.0
Capital Leases0.92.11.10.00.00.00.00.0
Def. Tax Liability0.00.00.00.00.00.00.00.0
Total Liabilities319.8340.0344.5271.0246.9329.9118.37.8
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt148.9153.8158.8163.8168.7172.3176.3178.6182.1180.5
Capital Leases1.21.31.82.12.42.63.11.10.90.5
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities373.1334.9335.0340.0331.3319.8331.6344.5296.4275.0
Total Common Equity TTM 2024202320222021202020192018
Common Stock0.00.00.00.00.00.00.00.0
Retained Earnings-93.42.2-143.3-272.1-453.6-488.2-422.9-242.7
Comprehensive Income-0.20.10.0-0.20.0-427.10.00.0
Total Common Equity538.6659.2467.0402.8186.597.2-11.681.5
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.00.00.00.00.00.00.00.00.00.0
Retained Earnings138.487.647.82.2-47.3-93.4-104.9-143.3-169.9-208.3
Comprehensive Income0.40.20.20.10.5-0.2-0.20.0-0.5-0.5
Total Common Equity835.1773.1720.5659.2596.8538.6515.4467.0481.3485.2
Other TTM 2024202320222021202020192018
Total Debt219.3181.4193.6191.6192.0194.397.90.0
Book Value538.6659.2467.0402.8186.597.2-11.681.5
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value835.1773.1720.5659.2596.8538.6515.4467.0481.3485.2
Cash Flow From Operating Activities TTM 20252024202320222021202020192018
Net Income115.0158.7145.5128.9181.534.6-36.9-152.0-39.9
Depreciation & Amortization24.425.324.124.423.418.810.23.20.2
Stock-Based Compensation38.344.942.631.726.215.74.79.91.1
Change Working Capital3.591.8-7.335.0-4.10.6-11.68.3-0.2
Change In Accounts Receivable-19.3-13.8-8.9-19.4-19.9-12.7-17.9-4.30.0
Change In Accounts Payable9.73.9-5.48.92.8-1.6-3.84.9-0.6
Change In Inventories-0.81.8-1.8-1.10.1-0.6-2.7-1.10.0
Other Non-cash Items107.427.544.212.93.52.74.955.10.0
Cash from Operations213.50.00.0219.4144.598.6-3.0-75.4-38.8
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income22.550.939.845.649.546.111.638.326.638.5
Depreciation & Amortization7.46.16.06.16.06.16.26.36.16.1
Stock-Based Compensation10.210.811.512.510.111.411.010.48.98.0
Change Working Capital74.032.113.5-29.615.823.9-20.7-17.731.66.7
Change In Accounts Receivable3.9-7.713.0-22.9-1.51.7-3.4-5.6-6.9-3.5
Change In Accounts Payable-8.60.010.80.03.20.00.00.06.20.0
Change In Inventories1.5-0.80.30.8-0.3-1.30.2-0.5-0.3-0.2
Other Non-cash Items-2.68.815.1-0.60.9-17.034.5-6.22.310.7
Cash from Operations0.00.00.00.00.00.00.00.076.763.1
Cash Flow From Investing Activities TTM 20252024202320222021202020192018
Capital Expenditure-0.7-19.6-1.2-0.3-40.2-100.3-2.0-127.1-1.3
Acquisitions-77.60.0-33.1-37.0141.80.00.00.00.0
Investments-100.9-86.2-105.3-127.5-110.70.00.00.00.0
Sales of Investment99.381.198.5118.39.10.00.00.00.0
Other Investing Activities-24.90.00.00.0-141.80.00.00.00.0
Cash from Investing-97.90.00.0-46.4-141.8-100.3-2.0-127.1-1.3
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-19.4-0.10.0-0.1-0.50.0-0.60.0-0.10.0
Acquisitions0.00.00.00.00.00.0-33.10.0-44.50.0
Investments-18.80.0-23.90.0-35.70.00.00.0-21.6-33.0
Sales of Investment20.60.019.30.030.00.00.00.022.632.2
Other Investing Activities0.00.00.00.00.00.00.00.07.6-0.8
Cash from Investing0.00.00.00.00.00.00.00.0-36.1-0.8
Cash Flow From Financing Activities TTM 20252024202320222021202020192018
Debt Repaid-16.60.00.0-1.3-2.0-222.5-120.60.00.0
Debt Issued44.4181.4-12.23.21.7220.2216.997.90.0
Issuance of Common Stock1.20.00.00.00.030.0147.60.00.0
Repurchase of Common Stock-100.30.00.0-100.00.00.0-0.20.0-3.2
Dividends Paid-55.30.00.00.00.00.0-200.30.00.0
Other Financing Activities-9.00.00.0-3.88.8199.9382.6143.824.8
Cash from Financing-115.70.00.0-105.66.87.4209.2143.821.6
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.0-3.8200.0
Debt Issued169.7-3.6-4.1-3.9-3.8-3.8-4.0-0.50.2205.6
Issuance of Common Stock0.00.00.00.00.00.00.00.00.00.2
Repurchase of Common Stock0.00.00.0-1.30.00.0-0.30.0-50.0-50.0
Dividends Paid0.00.00.00.00.00.00.00.0-55.30.0
Other Financing Activities0.00.00.00.00.00.00.00.055.5-255.1
Cash from Financing0.00.00.00.00.00.00.00.0-53.5-55.1
Cash position TTM 20252024202320222021202020192018
Net Change in Cash-0.1299.5141.367.49.55.7204.2-58.8-18.5
Closing Cash Balance317.3752.5453.3311.9244.5235.1229.425.284.0
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash105.5100.957.136.065.670.1-15.721.3-12.97.2
Closing Cash Balance752.5647.3546.3489.3453.3387.6317.6333.3311.9324.9
Free Cash Flow TTM 20252024202320222021202020192018
Free Cash Flow212.8347.9218.7219.1104.3-1.7-5.0-202.6-40.1
Real Free Cash Flow174.4303.0176.1187.478.1-17.4-9.7-212.5-41.2
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow126.0108.779.333.975.070.542.031.176.663.1
Real Free Cash Flow115.997.867.921.465.059.131.020.767.755.1
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E10.335.3-1.4
P/S1.96.69.4
P/B1.97.15.2
P/FCF5.477.3-1.5
Market cap$1.8$1.9
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %34.8 %0 %
Debt to Income107 %218.9 %0 %
Debt to Free cash flow56 %100.7 %0 %
Interest expense percentage7 %6.7 %44.7 %
Current ratio3.8 3.6 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE19 %77.1 %0 %
ROA13.1 %-1.1 %0 %
CapEx to Revenue0 %95.4 %0 %
RaD to Revenue0 %55.9 %0 %
ROEM3,240,496.3 946593

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin77.2 %71.4 %68.7 %
Operating margin24 %-84 %35.5 %
Net margin22.5 %-101.7 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0.7 %0 %
Dividend payout percentage0 %-167.1 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding58.7 mil 57.6 mil
Employee count0.3 tis 0.2 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás
Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader